Hip fractures Musculoskeletal Diseases Orthopaedics, gerentology
Conditions
Interventions
1. Treated group receive cholecalciferol 2.5 mg every 3 months
2. No intervention in control group
Sponsors
The Sir Jules Thorn Charitable Trust (UK)
Eligibility
Inclusion criteria
Inclusion criteria: All residents of residential homes except those with known hypercalcaemia, myeloma, sarcoidosis and cancer
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed